Skip to content
Screener

Vivani Medical VANI Q2 2025 earnings

Reported August 13, 2025 · Before market open

Revenue-
EPS-$0.12Miss by $0.02
EPS estimate-$0.10

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.07

Financials

Q2 2025

Income statement

See full
Revenue-—
Operating income-$7.5M-31.4%
Net income-$7.1M-33.4%
EPS (diluted)-$0.12-20.0%

Balance sheet

See full
Cash & equivalents$5.8M-75.7%
Total debt$18.6M-7.7%
Total equity$4.9M-79.4%
Total assets$28.9M-40.1%

Cash flow

See full
Operating cash flow-$6.1M-26.8%
CapEx$71.0K+91.9%
Free cash flow-$6.2M-27.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$75.24M+8.6%
Enterprise value$88.04M+34.3%

Returns & leverage

See full
Return on equity-177.7%-2,941pp
Debt / equity3.8×+2.9×
Current ratio1.3×-3.3×

FAQ

When did Vivani Medical report Q2 2025 earnings?
Vivani Medical (VANI) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Vivani Medical's Q2 2025 revenue and EPS?
Vivani Medical reported revenue of - and eps of $-0.12 for Q2 2025.
Did Vivani Medical beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.10 by $0.02.
How did Vivani Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 20.0% from $-0.10.
Where can I find Vivani Medical's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001753926-25-001328) and the 10-Q periodic report (0001753926-25-001330) directly on SEC EDGAR. The filing index links above go to sec.gov.